Tag: cancer
Another Cancer-Drug Failure Highlights Difficulties Facing Pharmas
by Melly Alazraki on Jan.28, 2011, under Towing
Sanofi-Aventis announced its cancer drug candidate iniparib failed in a late-stage clinical trial. Other pharmaceutical companies have also experienced recent setbacks as they scramble to bolster their pipelines ahead of the patent cliff, when they will be forced to compete with cheaper generics.
Continue reading Another Cancer-Drug Failure Highlights Difficulties Facing Pharmas
Another Cancer-Drug Failure Highlights Difficulties Facing Pharmas originally appeared on DailyFinance on Fri, 28 Jan 2011 12:30:00.
Filed Under: Company News, Columns, Health Care, Genzyme Corporation , Pfizer, Bristol-Myers Squibb, Sanofi Aventis, Novartis, Eli Lilly, Astrazeneca
Inside Wall Street: This Tiny Biotech Has Pfizer as a Big Backer
by Gene Marcial on Jan.24, 2011, under Towing
Lpath focuses on developing therapeutics that target bioactive lipids for treating a range of human diseases, including cancer and diseases that cause blindness. Its promising drugs have attracted attention — and lots of money — from Pfizer. More of both could be coming.
Continue reading Inside Wall Street: This Tiny Biotech Has Pfizer as a Big Backer
Inside Wall Street: This Tiny Biotech Has Pfizer as a Big Backer originally appeared on DailyFinance on Mon, 24 Jan 2011 07:30:00.
Filed Under: Company News, Columns, Investing, Health Care, Pfizer, Stock Picks
A Judge Snuffs Out New York City’s Gruesome Antismoking Ads
by Abigail Field on Dec.30, 2010, under Towing
A New York City health code regulation set to go into effect on Jan. 1 would have added some disturbing images to the Big Apple’s glittering background of advertising: Hideously accurate ads depicting the results of smoking. But a federal judge this week killed the city’s anti-smoking campaign before it could begin.
Continue reading A Judge Snuffs Out New York City’s Gruesome Antismoking Ads
A Judge Snuffs Out New York City’s Gruesome Antismoking Ads originally appeared on DailyFinance on Thu, 30 Dec 2010 12:25:00.
Filed Under: People, Health Care
Genzyme Tries to Convince Sanofi-Aventis Its MS Drug Is Worth More
by Melly Alazraki on Dec.20, 2010, under Towing
The U.S. biotech is holding an analyst and investor meeting focused on the commercial potential of its multiple sclerosis drug Campath. The goal: to convince Paris-based Sanofi-Aventis to raise its hostile takeover offer in a battle that has now gone on for five months.
Continue reading Genzyme Tries to Convince Sanofi-Aventis Its MS Drug Is Worth More
Genzyme Tries to Convince Sanofi-Aventis Its MS Drug Is Worth More originally appeared on DailyFinance on Mon, 20 Dec 2010 10:50:00.
Filed Under: Company News, Genzyme Corporation , Sanofi Aventis, Stocks in the News
The High Price — Emotional and Financial — of Pet Cancer
by Jonathan Berr on Nov.28, 2010, under Towing
As pet cancer increases and pricier treatments become available, the cost of keeping a pet healthy is on the rise. DailyFinance writer Jonathan Berr shares the story of his family dog Ruby’s bout with cancer. How much are you willing to spend on your best friend?
Continue reading The High Price — Emotional and Financial — of Pet Cancer
The High Price — Emotional and Financial — of Pet Cancer originally appeared on DailyFinance on Sun, 28 Nov 2010 07:00:00.
-
You Can Reach Us At:
For All Of Your Towing and Recovery Needs.
Tele: (847) 587-6076
Fax: (847) 587-8610 Some Of Our Pics
